PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatitis c |
| Symptom | C0239946|hepatic fibrosis |
| Sentences | 40 |
| PubMedID- 25685452 | These classes have been linked to respective clinical manifestations and depend on the stage of evolution of the host's immune response, extent of associated hepatic fibrosis and co-infection with salmonella or hepatitis c. |
| PubMedID- 21188198 | Although these studies included a small number of patients, the results encouraged clinicians to perform large studies to confirm the impact of maintenance therapy for chronic hepatitis c with advanced hepatic fibrosis. |
| PubMedID- 22509183 | The rate of progression of hepatic fibrosis in patients with chronic hepatitis c is reported to be 0.1-0.13 units/year . |
| PubMedID- 25203365 | In addition, arfi elastography exhibited acceptable diagnostic performance in the assessment of hepatic fibrosis in patients with hepatitis c. |
| PubMedID- 23161299 | Several simple laboratory tests, scores and indices have been proposed for the non-invasive prediction of hepatic fibrosis in patients with chronic hepatitis c. |
| PubMedID- 20711964 | Correlation between liver biopsy and fibrotest in the evaluation of hepatic fibrosis in patients with chronic hepatitis c. |
| PubMedID- 25651500 | Recently, a study has shown that liver stiffness measurement using fibroscan allows the accurate prediction of hepatic fibrosis in patients with chronic hepatitis c virus infection (6). |
| PubMedID- 26398503 | Transient elastography (te), also known as fibroscan), is a validated non-invasive method to evaluate hepatic fibrosis in patients with chronic hepatitis c viral infection and has a high level of accuracy for detecting severe fibrosis and cirrhosis . |
| PubMedID- 21931952 | Noninvasive assessment of hepatic fibrosis in patients with chronic hepatitis c using serum fourier transform infrared spectroscopy. |
| PubMedID- 22736923 | Aim: to evaluate the accuracy of specific biochemical markers for the assessment of hepatic fibrosis in patients with chronic hepatitis c virus (hcv) infection. |
| PubMedID- 25431223 | Objective: to evaluate clinicobiochemical factors predicting severe hepatic fibrosis in patients with chronic hepatitis c virus (hcv) infection. |
| PubMedID- 24524410 | Serum levels of apoptosis inhibitor of macrophage are associated with hepatic fibrosis in patients with chronic hepatitis c. |
| PubMedID- 21590334 | Aims: we utilized two different proteomic methods to identify serum proteins as candidate biomarkers to predict hepatic fibrosis stage in patients with chronic hepatitis c virus (hcv) infection. |
| PubMedID- 24346894 | After initial infection, 70% to 85% of the patients develop chronic hepatitis c with hepatic fibrosis. |
| PubMedID- 26312929 | Introduction: hepatic fibrosis progression in patients with chronic hepatitis c virus infections has been associated with viral and host factors, including genetic polymorphisms. |
| PubMedID- 26122702 | We confirmed that mir-214 was also upregulated with the progression of hepatic fibrosis in patients with chronic hepatitis c or b (fig. |
| PubMedID- 23382097 | The purpose of this study was to standardize preanalytical conditions for measurement of serum levels of fibrinogen alpha c-chain 5.9 kda fragment (fic 5.9) and to test the diagnostic value of this peptide for detection of early hepatic fibrosis in patients with hepatitis c virus (hcv)-related chronic hepatitis. |
| PubMedID- 21069731 | Chronic infection of hepatitis c virus (hcv) leads to hepatic fibrosis and subsequently cirrhosis, although the underlying mechanisms have not been established. |
| PubMedID- 24783307 Tests for Hepatic Fibrosis | To determine the efficacy and impact of contacting authors to clarify discordant data or obtain missing data for a systematic review on screening and diagnostic tests for hepatic fibrosis or cirrhosis in patients with chronic hepatitis c viral infection. |
| PubMedID- 26196278 | Previous studies have indicated that statins can prevent the progression of hepatic fibrosis in patients with hepatitis c virus (hcv) infection and advanced hepatic fibrosis, however data is lacking on patients who have yet to progress to cirrhosis. |
| PubMedID- 19874477 | Historically, liver biopsy (lb) was the sole method to evaluate the severity of hepatic fibrosis in patients with chronic hepatitis c infection. |
| PubMedID- 22140010 | Ultrasound-based transient elastography (te) is a promising noninvasive alternative to liver biopsy for the detection of hepatic fibrosis due to recurrent hepatitis c virus (hcv) after liver transplantation (lt). |
| PubMedID- 25376298 | Many studies have verified that rte is useful for the diagnosis of hepatic fibrosis in patients with chronic hepatitis c (chc). |
| PubMedID- 21699796 | Rate of progression of hepatic fibrosis in patients with chronic hepatitis c: results from the halt-c trial. |
| PubMedID- 23323000 | Aim: to investigate the association between interleukin-28b (il28b) genotype and response to treatment and hepatic fibrosis in patients with hepatitis c virus (hcv) genotype 4. |
| PubMedID- 20617863 | hepatic fibrosis in patients with chronic hepatitis c assessed by transient elastography: implications for determining the efficacy of antiviral therapy. |
| PubMedID- 25417617 | Background/aims: to evaluate the association between insulin resistance and hepatic fibrosis in patients with chronic hepatitis c. |
| PubMedID- 25760884 | The present study was aimed to evaluate whether serum opn could be used as a biomarker to assess the degree of hepatic fibrosis in patients with hepatitis c virus (hcv) infection. |
| PubMedID- 20088889 | Progression of initially mild hepatic fibrosis in patients with chronic hepatitis c infection. |
| PubMedID- 24640880 | Evaluation of liver stiffness measurement by fibroscan as compared to liver biopsy for assessment of hepatic fibrosis in children with chronic hepatitis c. |
| PubMedID- 24976280 | Conclusion: egy-score is a useful noninvasive panel of surrogate biomarkers that could accurately predict different stages of hepatic fibrosis in patients with chronic hepatitis c. |
| PubMedID- 25983139 | Age might confound the impact of the transmembrane 6 superfamily member 2 e167k polymorphism on hepatic fibrosis in hepatitis c virus-infected patients. |
| PubMedID- 25951491 | Background: several noninvasive tests have been developed to determine the degree of hepatic fibrosis in patients with chronic hepatitis c (chc) without performing liver biopsy. |
| PubMedID- 21644073 | Evaluation of serum igg, iga and igm levels as indicators of hepatic fibrosis in patients with chronic hepatitis c infection. |
| PubMedID- 21348908 | In a previous work, we demonstrated that the levels of urinary sulfated bile acids (usba) and serum total bile acids (tba) were correlated very well and also that usba was considered to be a more useful indicator of hepatic fibrosis than tba in patients with hepatitis c virus (hcv)-related liver diseases. |
| PubMedID- 24586712 | Similarly, iron reduction by phlebotomy or a low-iron diet suppresses hepatic fibrosis in patients with hepatitis c – and suppresses non-alcohol fatty liver disease . |
| PubMedID- 23428852 | Novel image analysis method using ultrasound elastography for noninvasive evaluation of hepatic fibrosis in patients with chronic hepatitis c. |
| PubMedID- 25622386 | This article presents an analysis of a recently published study of the survival experience among a group of patients treated for hepatitis c with advanced hepatic fibrosis/cirrhosis, divided into groups based on whether or not sustained virological response was achieved. |
| PubMedID- 23528378 | Background & aims: transient elastography (te) is a validated non-invasive tool to evaluate hepatic fibrosis in patients with hepatitis c virus (hcv) infection. |
| PubMedID- 25695872 | The plasma profile of sphingolipids in hepatic fibrosis patients with chronic hepatitis c (chc) is rarely considered at present. |
Page: 1